Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
JD Health International Inc banner

JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 36.06 HKD -0.77% Market Closed
Market Cap: HK$115B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
JD Health International Inc

Wall Street analysts forecast JD Health International Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JD Health International Inc is 68.18 HKD with a low forecast of 50.1 HKD and a high forecast of 97.75 HKD.

Lowest Forecast
Wall Street Target
HK$50.1
39% Upside
Average Forecast
Wall Street Target
HK$68.18
89% Upside
Highest Forecast
Wall Street Target
HK$97.75
171% Upside
Lowest Forecast
Price Target
50.1 HKD
39% Upside
Average Forecast
Price Target
68.18 HKD
89% Upside
Highest Forecast
Price Target
97.75 HKD
171% Upside
JD Health International Inc Competitors:
Price Targets

Revenue
Forecast

37% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
37% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 7 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

37% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
37% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 8 years is 13%.

What are analyst estimates?

Operating Income
Forecast

48% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
48% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 7 years, the compound annual growth rate for Operating Income has been 48%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Pre-Tax Income
Forecast

53% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
53% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 20%.

What are analyst estimates?

Net Income
Forecast

58% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
58% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Over the last 7 years, the compound annual growth rate for Net Income has been 58%. The projected CAGR for the next 4 years is 21%.

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other JD Health International Inc listings:
OTC • USD
JDHIF
 HKEX • CNY
86618
 F • EUR
8ZN
 OTC • USD
JDHIY
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is JD Health International Inc's stock price target?
Price Target
68.18 HKD

According to Wall Street analysts, the average 1-year price target for JD Health International Inc is 68.18 HKD with a low forecast of 50.1 HKD and a high forecast of 97.75 HKD.

What is the Revenue forecast for JD Health International Inc?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 12%.

What is the Gross Profit forecast for JD Health International Inc?
Projected CAGR
13%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 8 years is 13%.

What is the Operating Income forecast for JD Health International Inc?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Operating Income has been 48%. The projected CAGR for the next 8 years is 12%.

What is the Pre-Tax Income forecast for JD Health International Inc?
Projected CAGR
20%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 53%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for JD Health International Inc?
Projected CAGR
21%

Over the last 7 years, the compound annual growth rate for Net Income has been 58%. The projected CAGR for the next 4 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.